HER2-low breast cancer: evolution of HER2 expression from primary tumor to distant metastases

BACKGROUND: Breast cancer (BC) with low human epidermal growth factor receptor 2 (HER2) expression is attracting much attention due to the breakthrough progress of novel anti-HER2 antibody-drug conjugates. HER2 expression is examined in patients with HER2-low BC and their distant metastases in this...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Mengyuan, Li, Ming, Lv, Hong, Zhou, Shuling, Xu, Xiaoli, Shui, Ruohong, Yang, Wentao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10347880/
https://www.ncbi.nlm.nih.gov/pubmed/37442945
http://dx.doi.org/10.1186/s12885-023-11134-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10347880/
https://www.ncbi.nlm.nih.gov/pubmed/37442945
http://dx.doi.org/10.1186/s12885-023-11134-4

Ejemplares similares